Abstract: Compounds and methods are provided for the treatment of disease conditions in which modification of serotonergic receptor activity has a beneficial effect. In the method, an effective amount of a compound is adminstered to a patient in need of such treatment.
Type:
Grant
Filed:
March 6, 2001
Date of Patent:
November 9, 2004
Assignee:
Acadia Pharmaceuticals, Inc
Inventors:
Carl-Magnus A. Andersson, Glenn Croston, Eva Louise Hansen, Allan Kjaersgaard Uldam